MicroConstants, a bioanalytical and pharmacokinetic specialty CRO, has successfully completed a five-day inspection by the FDA for compliance with GLP regulations. The FDA inspected the company’s San Diego facility for overall GLP compliance and assessed lab areas and several method validations, three sample analysis projects, and a pharmacokinetic analysis report. The investigator reported zero findings, observations, or recommendations. “MicroConstants aims to have one of the most comprehensi...